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Abstract 
In the antiretroviral era children perinatally infected with HIV (PHIV+) are surviving into adulthood 
and are at risk for emotional and behavioural problems. Few studies of these problems have been 
conducted in low and middle income countries (LMIC) and even fewer in sub-Saharan Africa where 
the burden of the HIV epidemic remains heaviest. The aims of this study were to provide a 
quantitative description of emotional and behavioural problems in a group of children and 
adolescents with perinatally acquired HIV in South Africa compared to a group of well-matched 
HIV-negative controls and to identify demographic, biological, cognitive and contextual correlates 
of emotional and behavioural problems. 
A cross-sectional descriptive, analytical study was conducted. Participants were recruited from 
community and hospital based clinics. Within the HIV-infected group, children were further divided 
into three subgroups: PHIV+ children who had never been on antiretroviral therapy (ART naïve), 
PHIV+ children on ART and PHIV+ children on ART with a confirmed diagnosis of HIV-related 
encephalopathy (HIVE). Emotional and behavioural problems were assessed using the Child 
Behaviour Checklist (CBCL). Several measures were used to assess demographic, biological, 
cognitive and contextual correlates of problem behaviours: socio-demographic questionnaire, clinic 
records, neuropsychological test battery, Family Resource Scale, Family Support Scale and Center 
for Epidemiologic Studies-Depression Scale. Children were compared by HIV status on 
demographic, cognitive and contextual variables as well as the total and subscale scores of the 
CBCL. Multivariate comparisons of the influence of contextual and cognitive variables on CBCL 
total problems was performed using a hierarchical step-wise linear regression analytic procedure. 
The final sample (N=108) for data analysis included 78 PHIV+ children and 30 HIV-negative 
children. Groups were comparable with respect to demographic and contextual variables. Cognitive 
performance scores were significantly lower in the PHIV+ children when compared to HIV-negative 
controls (p<0.001). Rates of caregiver depression were higher in both groups than the lifetime 
prevalence rates reported in the South African population.  
	   5	  
The rate of emotional and behavioural problems in PHIV+ children in this sample (CBCL Total 
problems in the clinical range =14%) is lower than identified in previous LMIC studies but it is 
difficult to draw comparisons across studies with different methodologies. According to the final 
model greater total problems were associated with HIV-infection in children and having a depressed 
primary caregiver (F=8.57, df=5,102, p<0.01). Caregiver depression was a stronger predictor of total 
problems in controls (β coeff=0.6091, p<0.001) than PHIV+ children (β coeff=0.251, p<0.001). 
There was trend level evidence (p<0.1) toward greater problems in both male and older children. 
Within the HIV-infected group, HIV subgroup significantly predicted total problems. Children on 
ART had significantly fewer problems that ART naïve children (β coeff=7.169, p<0.001), or 
children on ART with encephalopathy (β coeff = 8.095, p<0.01). 
This study highlights the need for adequate screening of depression in the caregivers of HIV-
infected children. Treating caregiver depression may help reduce emotional and behavioural 
problems in children in our communities. This study also supports early initiation of ART in order to 
improve children’s quality of life.	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Chapter 1: Introduction 
1.1 Context 
The burden of the HIV epidemic remains heaviest in sub-Saharan Africa with 69% of people living 
with HIV residing in this region (AIDS, 2012). In recent years there have been gains in the 
management of the HIV epidemic and rates of incident adult HIV infection and AIDS-related 
mortality rates are declining in South Africa (AIDS, 2012). Expanded access to antiretroviral 
therapy (ART) has led to accelerated health gains and increased numbers of life-years (AIDS, 2012). 
Despite these transformations children continue to be infected with HIV and a relatively high 
proportion of South African children are still vulnerable to being infected with HIV perinatally 
(PHIV+) (Petersen et al., 2010). More than 90% of the children who acquired HIV infection in 2011 
live in sub-Saharan Africa (AIDS, 2012).  
As a result of the decline in AIDS-related mortality, large numbers of PHIV+ children are reaching 
adolescence and young adulthood. The illness is transforming from a terminal illness to a chronic 
condition and clinicians are now faced with new challenges in caring for PHIV+ children and 
adolescents. These youth are at increased risk of virus mediated neurocognitive deficits and they 
face many psychosocial challenges associated with living with a stigmatised illness and in an AIDS-
affected family (Boyes & Cluver, 2014; Cluver, Gardner, & Operario, 2008; 2007; Hoare et al., 
2012; Petersen et al., 2010). Research has focused on the biomedical outcomes in this population but 
there is an increasing awareness of mental health outcomes given the unique genetic, biological, and 
social risks children and adolescents face (Mellins & Malee, 2014). 
It has been well documented that children living with other chronic illnesses are at increased risk of 
psychological distress and behaviour problems (Oguz, Kurul, Dirik, & Eylül, 2002). International 
studies have shown that PHIV+ children are also at increased risk of experiencing behavioural and 
emotional problems (Mellins, Brackis Cott, Dolezal, & Abrams, 2006; Mellins et al., 2009; Nozyce 
et al., 2006). Behavioural and emotional problems in these children are important to study because 
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they have an impact on adherence to medical treatment, academic performance and quality of life for 
the individual and their caregivers. 
A range of emotional and behavioural problems have been studied in children and adolescents living 
with HIV. Some studies have used structured psychiatric interviews while others have used 
symptom checklists of youth or parent reported emotional and behavioural problems to determine 
prevalence of mental health problems (Mellins & Malee, 2014). Studies have found elevated rates of 
a range of psychiatric disorders including depression, anxiety, attention deficit and hyperactivity 
disorder (ADHD) and disruptive behaviour disorders (Gadow et al., 2010; Kapetanovic et al., 2011; 
Mellins et al., 2009; Scharko, 2010; Wood, Shah, Steenhoff, & Rutstein, 2009). Studies have shown 
increased rates of emotional and behavioural problems in HIV-infected children when compared to 
HIV-unexposed, negative controls and when compared to HIV-exposed but uninfected children 
(Bomba et al., 2010; Mellins et al., 2009). Others studies have shown that although the overall rates 
of behavioural and emotional problems were high, these were not greater than emotional or 
behaviour problems in HIV-exposed but uninfected children, healthy controls or children living with 
other chronic illnesses (Ananworanich, Jupimai, Mekmullica, Sosothikul, & Pancharoen, 2008; 
Bachanas et al., 2001; Gadow et al., 2010; 2012; Kang, Mellins, Dolezal, Elkington, & Abrams, 
2011; Malee et al., 2011; Mellins et al., 2011). 
When reviewing the literature, differences in study methodology and the lack of a standardised 
assessment of psychosocial problems makes it difficult to draw comparisons across studies. A 2014 
review of the literature on mental health functioning of PHIV+ youth by Mellins and Kalee 
highlights some of the limitations of research in this area (Mellins & Malee, 2014). Of the 38 studies 
included by the authors in the review the majority have been conducted in the United States and 
Europe, few studies used validated psychiatric interviews, behavioural measures were not 
comparable and not all studies used comparable comparison groups or comparison groups at all 
(Mellins & Malee, 2014). 
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There have been few studies of the emotional and behavioural problems of PHIV+ youth conducted 
in low and middle income countries (LMIC). Low socioeconomic status is an independent factor 
associated with increased rates of psychological and behavioural problems (Wadsworth & 
Achenbach, 2005). It is possible that in LMIC the rates of emotional and behavioural problems are 
high in both HIV-infected and comparison groups because of higher rates of poverty, trauma and 
adverse life events. A systematic review by Kieling et al reported prevalence rates of 10-20% of 
mental health problems in children and adolescents in LMIC (Kieling et al., 2011).  
A literature search was conducted to identify studies of emotional and behavioural problems in HIV-
infected children living in LMIC. A Pub Med search was conducted including the following search 
terms: children, adolescents, emotional and behavioural problems, HIV and perinatal HIV infection. 
Titles, abstracts and methodology of identified articles were reviewed. All articles that reported data 
on emotional and behavioural problems in PHIV+ children and adolescents that were conducted in 
LMIC were selected. Few studies were identified therefore articles where it was not made clear 
whether HIV was perinatally or behaviourally acquired were also included. Table 1 summarises the 
findings of studies identified by the literature search. 
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Table 1: Studies of Emotional and Behavioural Problem in Perinatally HIV-Infected Youth 

















n=66 HIV+ youth 
n= 64 children with 
haematological/oncological 
disease 
n=127 HIV - 
 
Youth 6-11 years 
Cg: CBCL 
 
No difference in 
behavioural and 
emotional problems 
between the groups 
 
42% of all children 




detected in 16% of 
6-11 y group and 
27% in 12-16 y 
group  
 
Age, gender, CD4 
count and CDC 











n= 140 HIV+ 
n= 301 HIV- 
 
Youth 6-11 y 
 
Cg: CBCL Higher rates of 
behavioural and 
emotional problems 
in HIV + youth 
(80.7%) compared 
to HIV- controls 
(18.3%) 
 
Youth from a 
disturbed family 
environment more 











n= 54 PHIV+ 
n= 165 HIV- 
 




CDI scores and rates 
of clinical 
depression (27.8%) 
were lower in 
PHIV+ group 












n= 50 PHIV+ on HAART 
n= 56 HIV - 
Youth 11-18 y 
Youth: YSR 
Cg: CBCL 
PHIV+ on HAART 
reported more 
internalizing 
problems and lower 
competence scores 
than controls  
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Cg reported greater 
impaired social 
competence abilities 











caregiver or in foster 
care associated with 
greater Cg reported 
behaviour problems 
Lowenthal 2012  






N= 692 HIV+ youth 
>90% n= PHIV + 
 
Youth 8-17 y 
Cg: PSC 17.3% met symptom 
cut off score of 20 
 
PSC scores were 











N= 127 HIV+ youth 
n= 123 PHIV+ 
 
Youth  11-15 y 
 
HIV- age and gender 
matched controls from 











Disclosure of HIV 
status did not have 
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Nöthling 2013 
(Nöthling, Martin, 





N= 70 mother child dyads 
infected with HIV 
 






44.3% children had 
total problems in the 
clinical range on 
CBCL 
 
50%  had 
internalising 
problems in clinical 
range and  
30% had 
externalizing 
problems in clinical 
range 
 
50% of caregivers 




Children of mother’s 
with depression 
were significantly 




Maternal PTSD had 
the greatest 
explanatory power 
for child behaviour 











n=25 HIV+ youth 
n=15 Cg 
 









loss of parents, 







disclosure and lack 
of financial, family 
and social support as 
challenges 
HIV information, a 
future orientation 
and social support 
identified as 
important for coping 
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and wellbeing of 
youth 
 
Financial and social 




















Youth 1-12 y 
Cg: CBCL PHIV+ youth had 
higher total and 
externalizing 
problem scores 
when compared to 
HIV– controls 
 
CBCL total problem 
scores in borderline 
clinical range (>60): 







PHIV+ youth with 
lower cognitive 
function more likely 
to have mental 
health problems on 
CBCL 
 
Timing of ART 












N=318 HIV+ on HAART 
 
Youth 6-14 y 
Cg: CBCL 39.3% of children 




Low family income, 
older age and 
parental loss were 
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• CBCL= Child Behaviour Checklist (Achenbach & Ruffle, 2000) 
• CDC= Center for Disease Control and Prevention 
• CDI= Children’s Depression Inventory (Trangkasombat & Likanapichitkul, 1997) 
• CESD= Center for Epidemiological Studies Depression Scale (Radloff, 1977) 
• Cg= Caregiver 
• HAART= Highly active antiretroviral therapy 
• HIV+= HIV positive youth (behaviourally and/or perinatally infected) 
• HIV-= HIV negative youth 
• HTS= Harvard Trauma Scale (Mollica et al., 2004) 
• ICD-10= International Statistical Classification of Diseases and Related Health Problems 
• PHIV+ = Youth perinatally infected with HIV 
• PHEU= Perinatally HIV exposed but uninfected youth 
• PSC= Paediatric Symptom Checklist (Jellinek et al., 1988) 
• PTSD= Posttraumatic Stress Disorder 
• SDQ-P= Strength and Difficulties Questionnaire parent version (“Psychometric properties 
of the strengths and difficulties questionnaire.,” 2001) 
• SDQ-P= Strength and Difficulties Questionnaire youth version (Goodman et al., 1998) 
• SRQ-25= Self Reporting Questionnaire 25 (Harding et al., 1980) 
• Y=Years 
• YSR= Youth Self-Report form (Achenbach, 1991) 
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These studies show that HIV-infected youth living in LMIC have high rates of emotional and 
behavioural problems with reported rates between 17 and 80%. As discussed above differences in 
study design, sample size and symptom measures make it difficult to draw comparisons across these 
studies. The most commonly used outcome measure of emotional and behavioural problems was the 
Child Behaviour Checklist. Only one African study included a control group and it can be argued 
that a British community sample is not a valid comparison group when comparing rates of mental 
health problems as the control group was only matched for age and gender (Menon et al., 2007). 
Several studies in LMIC looked at predictors or correlates of mental health in HIV-infected youth, as 
summarised in Table 2. 
Table 2: Variables Correlated with Greater Rates of Emotional and Behavioural Problems in 
Studies of Emotional and Behavioural Problems in Perinatally HIV Infected Youth Conducted 
in Low and Middle Income Countries 
Demographic Variables Biological Variables Psychological 
Variables 
Contextual Variables 
Older age (>10 years) Virological failure  
 







Living with a 
caregiver or in foster 
care 
 










Mellins and Malee’s review, which included five of the studies in Table 1 (Lee et al., 2011; 
Lowenthal et al., 2012; Menon et al., 2007; Petersen et al., 2010; Puthanakit et al., 2013), found 
considerable variability and inconsistency in study findings of correlates of mental health problems 
in PHIV+ youth (Mellins & Malee, 2014). Despite the conflicting findings, the reviewers highlight 
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the increasing evidence supporting the importance of contextual influences such as caregiver mental 
health which is associated with PHIV+ youth mental health (Mellins & Malee, 2014). Caregiver 
depression has been associated with youth mental health problems in other populations (Billings & 
Moos, 1986; Cummings, Keller, & Davies, 2005; Luoma et al., 2001).  
Overall there have been few studies of emotional and behavioural problems in HIV-infected children 
conducted in LMIC and even fewer studies conducted in the South African context. Cluver has done 
extensive research looking at mental health outcomes in South African children orphaned by HIV 
that has shown increased rates of emotional and behavioural problems (Cluver et al., 2008; Cluver, 
Orkin, Boyes, Gardner, & Nikelo, 2012; Cluver et al., 2007; Cluver & Gardner, 2006; 2007; Cluver, 
Bowes, & Gardner, 2010). However, this research did not identify the HIV status of the children and 
has therefore not been included in Table 1 above. Some of these children may have been perinatally 
infected with HIV.  
Local data has value because of the unique biological, psychological and social contextual factors of 
our population. The aims of this study are to provide a quantitative description of emotional and 
behavioural problems in a group of PHIV+ children and adolescents in South Africa compared to a 
group of well-matched HIV-negative controls and to identify demographic, biological, cognitive and 
contextual correlates of emotional and behavioural problems. An understanding of the rates of 
emotional and behavioural problems as well as the correlates of these problems in a South African 
sample can help to motivate for medical, educational and social services for this vulnerable 
population.  
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1.2 Ethical Considerations 
Ethics approval for this study was obtained from the Human Research Ethics Committee of the 
Faculty of Health Sciences at the University of Cape Town (HREC REF: 701/2013) (Appendix A). 
This study was nested in a larger study which obtained ethical approval from the same committee 
(HREC REF 406/2010). Permission was obtained from both the Department of Health (Appendix B) 
and the Department of Education (Appendix C) to recruit participants from clinics and schools. This 
study adheres to the principles of the Declaration of Helsinki (Association, 2008). 
Confidentiality: All data collected was kept strictly confidential. Completed instruments and 
measures were stored in a locked filing cabinet that could only be accessed by the research team. 
Participants were identified in the database by a participant number only and the database was stored 
on a secure server. Caregivers and children will not be identified by name in any publications or 
presentations. Caregivers were asked to give consent for any reports or feedback to be given to the 
managing medical team or school. 
Informed consent: Caregivers were given information about the study purpose, study procedures and 
risks of and benefits of participation in the study. Caregivers were asked to sign informed consent 
forms. The consent form was available in English and isiXhosa and provided detailed information 
regarding the study. The consent form and information form were read to the parents in their own 
language if they were unable to read the form themselves. There were separate consent forms for 
HIV-infected (Appendix D) and HIV-negative child participants (Appendix E). Caregivers were 
asked to provide consent for themselves and their children. All children in the study were below 18 
years of age and therefore could not legally give informed consent. Children, where possible, were 
asked to give assent for their participation in the study. Caregivers and children could withdraw from 
the study at any time. Participants were not disadvantaged in any way if they chose to withdraw 
from the study. 
Risks of participation: There were no direct physical or psychological risks in participating in the 
study. Blood was only taken if a recent (less than 3 months) CD4 count or viral load were not 
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available. Blood taking was done in line with clinic schedules and standard care in order to minimise 
discomfort. Blood was taken by a professional licensed to do so.  
Some of the questions in the measures asked about sensitive information and may have caused 
emotional distress to participants. Children may have found the cognitive testing stressful. The 
research team approached all participants with empathy and sensitivity. Caregivers and children 
were not coerced into completing any instruments or measures. The testing was spread over time to 
allow children to have adequate breaks. Children received a certificate and small gift after 
completion of the study regardless of how many of the instruments or measures were completed. 
Caregivers and children were not disadvantaged in any way if they were not able to complete the 
measures.  
Some of the instruments and measures detected a possible medical or psychiatric problem. When 
needed; caregivers and children were referred for medical, psychiatric, psychological and social 
assessment and intervention.  
Benefits of participation: There was no direct benefit to caregivers and children in participating in 
the study. Reports detailing the findings of the biological, cognitive and behavioural measures were 
provided (with caregiver consent) to caregivers, schools and managing clinicians. These reports 
were used to guide clinical decisions and motivate for further assessment and intervention where 
needed. The findings from the study will be published in a journal and presented at a conference and 
will hopefully provide useful information to guide clinical practice and resource allocation. 
Compensation: Adult participants were compensated with a R50 travel reimbursement and a R50 
food voucher. Children were given a certificate and a small prize e.g. T-shirt, pencil bag.  
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1.3 Author Guidelines 
The journal chosen for submission of the manuscript is AIDS Care. AIDS Care is accredited by the 
South African Department of Higher Education. AIDS Care is a peer reviewed, monthly journal with 
an impact factor of 2.194 (psc.isr.umich.edu, n.d.). The journal covers a range of HIV/AIDS 
psychological and socio-medical related subjects including mental health in HIV affected children 
and youth (tandfonline.com, n.d.). The journal has previously published studies of emotional and 
behavioural problems in HIV-infected youth conducted in Africa (Tadesse et al., 2012). This journal 
was chosen because it covers articles on the emotional and behavioural aspects of HIV in children 
and youth and because it has an appropriate readership which according to the publisher’s website 
includes HIV workers, psychologists, psychiatrists, clinicians, social workers, nurses, health 
education teachers, Public Health specialists and counselors (tandfonline.com, n.d.). The content of 
the manuscript would be relevant to this readership and help improve clinical practice. Original 
articles can be up to 3000 words excluding the abstract, references and tables. The instructions for 
authors are described in detail in Appendix F. 
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Abstract 
 
In the antiretroviral (ART) era children perinatally infected with HIV (PHIV+) are surviving into 
adulthood and are at risk for emotional and behavioural problems. Few studies of these problems 
have been conducted in low and middle income countries and even fewer in sub-Saharan Africa 
where the burden of the HIV epidemic remains heaviest. The aims of this study were to provide a 
quantitative description of emotional and behavioural problems in a group of PHIV+ children and 
adolescents in South Africa compared to a group of well-matched HIV-negative controls and to 
identify demographic, biological, cognitive and contextual correlates of emotional and behavioural 
problems. 
A cross-sectional descriptive, analytical study was conducted. Participants were recruited from 
community and hospital based clinics. Emotional and behavioural problems were assessed using the 
Child Behaviour Checklist (CBCL). Several measures were used to assess demographic, biological, 
cognitive and contextual correlates of problem behaviours. Children were compared by HIV status 
on demographic, cognitive and contextual variables as well as the total and subscale scores of the 
CBCL. Multivariate comparisons of the influence of contextual and cognitive variables on CBCL 
total problems was performed using a hierarchical step-wise linear regression analytic procedure. 
According to the final model greater problems were associated with HIV-infection in children and 
having a depressed primary caregiver (F=8.57, df=5,102, p<0.01). In the HIV group, children on 
ART had significantly fewer problems that ART naïve children (β coeff=7.169, p<0.001), or 
children on ART with encephalopathy (β coeff = 8.095, p<0.01). 
This study highlights the need for adequate screening of depression in the caregivers of HIV-
infected children. Treating caregiver depression may help reduce emotional and behavioural 
problems in children in our communities. This study also supports the early initiation of ART in 
order to improve children’s quality of life. 
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Main text 
Background  
The burden of the HIV epidemic remains heaviest in sub-Saharan Africa with 69% of people living 
with HIV residing in this region (AIDS, 2012). Despite gains in the management of HIV a relatively 
high proportion of South African children are still vulnerable to being infected with HIV perinatally 
(PHIV+) (Petersen et al., 2010). PHIV+ children are living longer in the antiretroviral (ART) era and 
they face challenges of virus mediated neurocognitive deficits and psychosocial difficulties 
associated with living with a stigmatised illness and in AIDS-affected families (Boyes & Cluver, 
2014; Cluver, Gardner, & Operario, 2008; 2007; Hoare et al., 2012; Petersen et al., 2010).  
It has been well documented that children living with other chronic illnesses are at increased risk of 
psychological distress and behaviour problems (Oguz, Kurul, Dirik, & Eylül, 2002). Studies in 
Europe and the United States have shown increased rates of emotional and behavioural problems in 
HIV-infected children when compared to HIV-exposed but uninfected children and HIV-negative 
controls (Bomba et al., 2010; Mellins et al., 2009; Menon, Glazebrook, Campain, & Ngoma, 2007). 
Others studies have shown that although the overall rates of behavioural and emotional problems 
were high these were not greater than emotional or behaviour problems in HIV-exposed but 
uninfected children, healthy controls or children living with other chronic illnesses (Bachanas et al., 
2001; Gadow et al., 2010; Kang, Mellins, Dolezal, Elkington, & Abrams, 2011; Malee et al., 2011; 
Mellins et al., 2011). One of the major limitations of the literature is that overall there have been few 
studies of emotional and behavioural problems in HIV-infected children conducted in low and 
middle income countries (LMIC) (Mellins & Malee, 2014). 
Studies conducted in LMIC have found high rates (17-80%) of emotional and behavioural problems 
in HIV-infected children (Ananworanich, Jupimai, Mekmullica, Sosothikul, & Pancharoen, 2008; 
Grover, Pensi, & Banerjee, 2007; Louthrenoo, Oberdorfer, & Sirisanthana, 2014; Lowenthal et al., 
2012; Menon et al., 2007; Musisi & Kinyanda, 2009; Nöthling, Martin, Laughton, Cotton, & Seedat, 
2013; Puthanakit et al., 2013; Tadesse, Tsehay, Belaineh, & Alemu, 2012). Few LMIC studies have 
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included control groups and across studies these control groups are not comparable (Ananworanich 
et al., 2008; Grover et al., 2007; Lee, Chhabra, & Oberdorfer, 2011; Louthrenoo et al., 2014; Menon 
et al., 2007; Puthanakit et al., 2013). Reported rates of emotional and behavioural problems have 
been both greater than (Grover et al., 2007; Louthrenoo et al., 2014; Puthanakit et al., 2013) and 
equal to rates in HIV-negative controls (Ananworanich et al., 2008).  
There is considerable variability and inconsistency in study findings of correlates of mental health 
problems in PHIV+ youth (Mellins & Malee, 2014). Despite conflicting findings there is increasing 
evidence supporting the importance of contextual influences especially caregiver mental health 
which is associated with PHIV+ youth mental health (Mellins & Malee, 2014). Studies conducted in 
LMIC have identified several correlates of greater emotional and behaviour problems in HIV-
infected children including older child age, greater viral load, lower cognitive function, higher health 
problems, lower income, loss of parents, disturbed family environment, living with a caregiver or in 
foster care, caregiver depression and caregiver posttraumatic stress disorder (PTSD) (Grover et al., 
2007; Louthrenoo et al., 2014; Lowenthal et al., 2012; Nöthling et al., 2013; Puthanakit et al., 2013; 
Tadesse et al., 2012). 
The aims of this study are to provide a quantitative description of emotional and behavioural 
problems in a group of PHIV+ in South Africa compared to a group of well-matched HIV-negative 
controls and to identify demographic, biological, cognitive and contextual correlates of emotional 
and behavioural problems. 
Methods 
Study design 
A cross-sectional descriptive, analytical study was conducted on a group of PHIV+ children ages 6-
16 years and a comparison group of HIV-negative, unexposed children from the same socio-
economic communities. 
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Sample 
PHIV+ children were recruited from Infectious Diseases clinics at Khayelitsha Site C, Woodstock 
and Mitchells Plain Community Health Clinics (CHCs) as well as the paediatric neurology service at 
Red Cross War Memorial Children’s Hospital and the Groote Schuur Hospital Paediatric HIV clinic 
in Cape Town, South Africa. A positive diagnosis of HIV including confirmatory tests was an 
inclusion criterion. Caregivers were asked whether transmission was perinatal and as far as possible 
this was confirmed by reviewing clinical records. Within the HIV-infected group, children were 
further divided into three subgroups: PHIV+ children who had never been on antiretroviral therapy 
(ART naïve), PHIV+ children on ART and PHIV+ children on ART with a confirmed diagnosis of 
HIV-related encephalopathy. 
HIV-negative, unexposed control children were recruited from schools and by word of mouth in the 
same communities as the CHCs. Controls were matched for age, gender, language and race.  
This study formed part of a larger study which included brain imaging therefore children with other 
serious medical comorbidities, previous central nervous system conditions, previous head injuries, a 
history of drug or alcohol exposure in pregnancy, a history of perinatal complications that could 
have caused brain injury or any contra-indication to magnetic resonance imaging were excluded.  
Study procedure 
Ethics approval for this study was obtained from the Human Research Ethics Committee of the 
Faculty of Health Sciences at the University of Cape Town (HREC REF: 701/2013). Permission was 
obtained from both the Department of Health and the Department of Education to recruit participants 
from clinics and schools. Caregivers had to be able to provide fully informed consent for the child to 
participate in the study. Any subjects who were diagnosed with medical or psychiatric conditions 
during the study were referred for further assessment and management.  
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Measures 
All instruments used were translated into isiXhosa and back-translated into English by qualified 
translators at the University of Stellenbosch Language Center. The instruments were administered 
by two researchers, a clinical social worker and a psychology masters student, who received training 
in the instruments from a neuropsychologist. The researchers administering these instruments were 
fluent in English and isiXhosa.  
Emotional and behavioural problems 
The main outcome measure of this study was emotional and behavioural problems which was 
measured using the Child Behaviour Checklist CBCL/6-18 version (Achenbach & Ruffle, 2000). 
The CBCL/6-18 is a standardised caregiver rating scale used to identify emotional and behavioural 
problems in children between ages 6 and 18 years. Caregiver was defined in this study as the person 
taking primary responsibility for caring for the child. The CBCL has 113 problem behaviour items. 
Caregivers respond using a 3-point Likert scale (0= Not True, 1= Somewhat or Sometimes True, 2= 
Very true or Often True) based on observed behaviour over the previous 6 months. The CBCL has 
been used globally in clinical and research settings and it has been validated in non-English speaking 
children from varying social groups and with varying physical and mental health conditions 
(Albores-Gallo et al., 2007; Tadesse et al., 2012). The CBCL preschool version has been used 
successfully to measure emotional and behavioural problems in South African children (Nöthling et 
al., 2013).  
Demographic Variables 
Child age and gender were asked about in a socio-demographic questionnaire (Appendix G). Age 
was analysed as a dichotomous variable; participants ages 10 years or older were grouped as 
adolescents and participants younger than 10 years of age as children. This cut-off is consistent with 
World Health Organization definition of adolescence (World Health Organization, 2014). 
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Biological Variables 
Child HIV status was confirmed by reviewing clinical records for a confirmatory Elisa test. CD4 
count and viral load (VL) were determined by reviewing clinical records. Blood samples were taken 
if a recent (less than 3 months) test was not available. VL was analysed as a dichotomous variable 
because of the extreme values with VL less or equal to 40 being classed as undetectable versus VL 
greater than 40. ART schedule was obtained from the participant’s clinical records. HIV 
encephalopathy was determined by a neuromedical examination performed on all HIV-infected 
children by a paediatric neurodevelopmental specialist.  
Psychological Variables 
A Cognitive performance score for children was calculated as an average of z-scores from a battery 
of neuropsychological tests. For large test batteries with age adjustment and normative data (WASI, 
TEA-ch, Nepsy) the scaled scores were used in the z-score calculation. Scaled scores were 
calculated according to the normative scores provided in individual test manuals or using the 
appropriate software. For timed tests and all other tests the raw scores were used in the z-score 
calculation. Cognitive domains known to be affected in PHIV+ children were selected for the 
calculation (Laughton, Cornell, Boivin, & Van Rie, 2013) (Table 1). All instruments are 
standardized, have good psychometric properties and have been used in paediatric neuropsychology 
research and clinical assessment in South Africa (Hoare et al., 2012).  
Contextual Variables 
Relationship of caregiver to the child was asked about in the socio-demographic questionnaire. 
Caregivers were classified into two groups; biological father or biological mother and other. 
Household crowding was measured using information from the socio-demographic questionnaire 
and calculated as number of people living in the house divided by number of rooms. 
The Family Resources Scale (FRS) is a standardized 30-item scale used to assess the extent to which 
resources are perceived to be adequate in households of young children (Dunst & Leet, 1987). 
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Caregivers rate the extent to which each of the resources is adequate on a 5 point Likert scale (1= 
Not at all adequate, 2= Seldom adequate, 3= Sometimes adequate, 4= Usually adequate, 5= Almost 
always adequate). The FRS has been shown to be a reliable and valid tool for assessing perceived 
adequacy of resources among economically diverse families of children with emotional and 
behavioural disorders (Brannan, Manteuffel, Holden, & Heflinger, 2006). The FRS has not been 
used in previously-published HIV-related studies of South African samples. 
The Family Support Scale (FSS) is a standardized 18-item scale used to assess caregivers’ 
satisfaction with the perceived level social support they receive in raising young children (Dunst, 
Trivette, & Cross, 1986). Caregivers rate how helpful various sources of support have been in terms 
of raising their children on a 5 point Likert scale (1= Not at all helpful, 2= Sometimes helpful, 3= 
Generally helpful, 4= Very helpful, 5= Extremely helpful). The internal consistency and test-retest 
reliability of the FRS have been found to be moderately high in studies of low-income families 
(Hanley, Tassé, Aman, & Pace, 1998). The FSS has not been used in previously-published HIV-
related studies of South African samples. 
Caregiver depression was measured using the Center for Epidemiologic Studies-Depression Scale 
(CESD) a 20 item self-report scale designed to measure depression symptomatology in the general 
population (Radloff, 1977). The CES-D measures common symptoms of major depression such as 
low mood, feelings of guilt and worthlessness, psychomotor retardation, loss of appetite, and sleep 
disturbance. Caregivers rate how often they have felt or behaved in a certain way in the previous 
week on a 3 point Likert scale (0=Rarely or None of the Time, 1= Some or little of the Time, 2= 
Moderately or Much of the Time, 3= Most or Almost All the Time). The CESD has been validated 
in South Africa and has been shown to be an effective screening tool for depression in HIV-infected 
adults (Landon et al., 2008; Singh, Sunpath, John, Eastham, & Gouden, 2008). A cut-off score of 16 
is considered to be depression and has been used in previous South African studies (Nöthling et al., 
2013). 
  
	   35	  
Data analysis 
Data was captured into an Excel spread sheet and analyses were conducted using the R statistical 
computing language (version 3.1.2). Children were compared by HIV status on demographic, 
psychological and contextual variables, as well as the total and subscale scores of the CBCL. Chi-
square tests were conducted for categorical variables, with continuous data compared by means of 
two-sample t-tests, or the non-parametric Mann-Whitney tests where assumptions of normality were 
violated.  
Multivariate comparisons of the influence of contextual and cognitive variables on CBCL total 
problems was performed using a hierarchical step-wise linear regression analytic procedure. A block 
of contextual variables was added to a basic model including HIV status and children's age and 
gender as nuisance covariates. An iterative model comparison algorithm was subsequently run, as 
implemented using R's step function, in which variables that made the least contribution to model fit 
(as assessed using the AIC metric) were removed in a step-wise fashion from the model. The final 
model was attained when removal of any additional variables would result in a statistically 
significant decrement in model fit. In order to ensure that the final model selection was not 
dominated solely by the statistical properties of the data, the influence of cognitive performance was 
only assessed after the backward stepwise function had identified significant predictor terms from 
the block of contextual variables, as well as their interactions with HIV status.   
Results 
A total number of 120 children and adolescents were recruited. The final sample (N=108) for data 
analysis included 78 PHIV+ children and 30 HIV-negative control children. The demographic, 
psychological and contextual variables are compared between the two groups in Table 2. The mean 
age of children in this study was 10 years split approximately equally in children (50.9%) and 
adolescents (49.1%). The groups were comparable with respect to demographic and contextual 
variables. Cognitive performance scores were significantly lower in the PHIV+ children when 
compared to the HIV-negative controls (p<0.001). Using a cut-off of 16 on the CESD, 43.6% of 
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caregivers of PHIV+ children and 50% of caregivers of HIV-negative controls screened positive for 
depression with no significant difference between groups.  
The demographic, psychological, contextual and biological variables are compared between the 
three subgroups in Table 3. The demographic variables are comparable between the subgroups 
except for the encephalopathy group being younger than the ART treated group. The psychological 
and contextual variables were not significantly different between the groups. There was trend-level 
evidence (p< 0.1) for greater perceived resources in the encephalopathy group. For the biological 
variables, viral loads were significantly higher in the ART-naïve group (60% detectable) when 
compared to the ART-treated (21% detectable) and encephalopathy groups (11% detectable) (p= 
0.01) while CD4 count was significantly lower in the ART-naïve group when compared to the ART-
treated and encephalopathy groups (p=0.02).  
Table 4 shows a correlation matrix indicating the relationships between the contextual variables for 
the total sample. Greater depression was significantly associated with lower perceived resources (p= 
0.01) and there is a significant positive correlation between FRS and FSS scores. 
Table 5 shows the prevalence of internalizing, externalizing and total problems in the PHIV+ 
children and control group at the clinical (>65) and borderline (>60) cut-off ranges of the CBCL. 
There are no statistically significant differences in between group comparisons. 
Table 6 shows the CBCL scores and between group comparisons for the PHIV+ children and HIV-
negative control children. No statistically significant differences were observed in the between group 
univariate tests of CBCL total, internalizing and externalizing problem scores. The somatic problems 
subscale (p=0.06) trended towards being significantly greater in the PHIV+ group when compared to 
controls.  
Appendix H shows the CBCL results across the three HIV subgroups. Some variability was 
observed with respect to the distribution of total problem scores between these groups, with children 
on ART having fewer emotional and behavioural problems when compared to ART naïve and 
children on ART with encephalopathy (F=6.188, df=2.75, p<0.01).  
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After controlling for gender and age, the contextual variables retained following step-wise 
regression included caregiver depression and the interaction between caregiver depression and HIV 
status. The regression model of total problems on HIV status and depression, as well as their 
interaction, was significant (F=8.57, df=5,102, p<0.01), explaining over a quarter of the variability 
in total problems (adjusted R2=26.1%). The addition of the cognitive performance variable did not 
improve the prediction of total problems. Table 7 shows the estimates for the final model of total 
problems. 
According to the final model, greater problems were associated with HIV-infection in children and 
having a depressed primary caregiver. There was trend-level evidence (p<0.1) for greater problems 
in both male and older children. Depression was a stronger predictor of total problems in controls (β 
coeff=0.6091, p<0.001) than PHIV+ children (β coeff=0.251, p<0.001), after controlling for child 
gender and age. Figure 1 shows a scatter plot of the interaction between HIV status, caregiver 
depression and CBCL Total Problem scores. In a model assessing the effect of biological variables 
(HIV subgroup, CD4 count, viral load) within the HIV-infected participants, only HIV subgroup 
significantly predicted total problems. The ART treated group presented with fewer problems than 
either the PHIV+ children on ART with encephalopathy (β coeff=8.095, p<0.01) or the ART naïve 
children (β coeff=7.169, p<0.001), with equally high rates of total problems in the latter two groups 
(β coeff=-0.926, p=0.738). 
Discussion 
This study examined the prevalence and correlates of emotional and behaviour problems in a sample 
of PHIV+ children compared to well-matched HIV-negative controls. There were four main 
findings. First, this study found that 14% of PHIV+ children had emotional and behavioural 
problems using the CBCL total problems clinical cut-off. Second, demographic and contextual 
variables were comparable between the two groups except cognitive performance scores which were 
significantly lower in the PHIV+ group. Third, caregiver depression predicted greater total problems 
in both groups; this correlation was stronger in the control group. Fourth, PHIV+ children on ART 
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had fewer emotional and behavioural problems than PHIV+ on ART with encephalopathy and ART 
naïve PHIV+ children. 
The rate of emotional and behavioural problems in our study is lower than other LMIC studies. It is 
difficult to draw comparisons across studies with different methodologies and this lower rate may 
reflect more rigorous methodology and clearly defined measure cut-offs rather than true lower 
prevalence. Two other African studies have used the CBCL (Nöthling et al., 2013; Tadesse et al., 
2012). Tadesse’s Ethiopian study reported rates of 39% of overall emotional and behavioural 
problems in 6-14 year old HIV-infected children on ART, however it is not clear from the 
methodology how this percentage was calculated (Tadesse et al., 2012). In their sample (N=318) 
54.1% of children had a history of hospital admission for more than 5 days, 3.5% due to seizures, 
whereas our study excluded children with serious medical comorbidities and previous central 
nervous system conditions. Children with serious medical illnesses and seizure disorders would be at 
greater risk for behaviour problems. Tadesse’s study used the United Stated reference norm group 
for CBCL scoring while our scoring was based on multicultural norms which may also explain the 
higher reported rates in their sample. Nöthling’s longitudinal South African study of 70 mother-child 
dyads infected with HIV found rates 44% of problem behaviours using the clinical cut-off on the 
CBCL preschool version in a sample of younger PHIV+ children assessed at 42 months (Nöthling et 
al., 2013). These participants were also recruited from CHCs in South Africa however the sample 
size was smaller and children younger than the sample in our study making comparisons across 
these studies difficult. Parents of older children may be used to certain behaviours and therefore less 
likely to report them as problematic. In our sample HIV-infection in children predicted greater 
problems which is in keeping with most LMIC studies that have reported higher rates of emotional 
and behaviour problems in HIV-positive youth when compared to HIV-negative controls (Grover et 
al., 2007; Louthrenoo et al., 2014; Menon et al., 2007; Puthanakit et al., 2013).  
The finding that cognitive performance scores were significantly lower in the PHIV+ group is not 
surprising as the cognitive domains selected for the score were chosen because they are known to be 
affected in PHIV+ youth (Laughton et al., 2013). Despite being significantly lower, cognitive 
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performance scores did not predict greater emotional and behavioural problems as has been shown 
in other studies (Malee et al., 2011; Nozyce et al., 2006; Puthanakit et al., 2013). It is possible that 
behavioural problems as a result of cognitive difficulties, particularly externalizing behaviours, may 
only manifest in older children. The average age of children in our sample was 10 years and there 
was trend-level evidence for greater problems in older children. The CBCL relies on subjective 
reporting by caregivers and caregivers of children with cognitive problems may have become used 
to certain behaviours and therefore not have reported them. 
Caregiver depression has been correlated with greater emotional and behavioural problems in other 
studies of PHIV+ youth (Mellins & Malee, 2014) and youth from other populations (Billings & 
Moos, 1986; Cummings, Keller, & Davies, 2005; Luoma et al., 2001). The correlation between 
caregiver depression and behaviour problems was less strong in the PHIV+ group which may be 
because of the impact of other HIV related factors such as child nadir CD4 count, child age of ART 
initiation, parental loss and caregiver HIV status that were not measured in this study. The rates of 
caregiver depression in both groups were higher than life time prevalence rates of depression 
reported in South Africa (9.7%) (Tomlinson, Grimsrud, Stein, Williams, & Myer, 2009). All 
participants in our study came from communities with limited resources and multiple psychosocial 
stressors which may explain the higher rates of depression. In our sample greater depression was 
correlated with lower perceived resources. Nöthling et al’s South African study reported similarly 
high caregiver depression rates of 50% in a comparable community sample (Nöthling et al., 2013). 
The demographic characteristics of caregivers in our sample may also account for the high rates of 
depression. The majority of caregivers were female (97%), 60% were single, widowed or divorced 
and 65% were unemployed. These are all factors known to increase vulnerability to depression 
(McKee-Ryan, Song, Wanberg, & Kinicki, 2005; Weissman et al., 1996). The demographic risk 
factors and stressors facing these caregivers appear to put them at risk of depression whether or not 
they are caring for an HIV-infected child. LMIC studies have shown that disturbed family 
environment, living with a caregiver or in foster care, parental loss and low income are associated 
with greater emotional and behavioural problems in PHIV+ children (Grover et al., 2007; 
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Louthrenoo et al., 2014; Tadesse et al., 2012). Apart from caregiver depression none of the other 
contextual variables measured in our study were correlated with greater problem behaviours in the 
regression analysis. Lack of resources appear to mediate the effect on problem behaviour through 
higher rates of caregiver depression. Of all the many stressors faced by HIV-affected families and 
families living in difficult socio-economic environments this study highlights the importance of 
caregiver mental health. Depression can be screened for and treated and this may help to reduce 
child behaviour problems. 
Of the biological variables, PHIV+ children on ART had fewer problems than PHIV+ on ART with 
encephalopathy and ART naïve PHIV+ children. This finding is interesting because children who 
have not required ART may be perceived as being healthier despite evidence of cognitive 
dysfunction and virus mediated neurological damage (Hoare et al., 2012). Early initiation of ART is 
now well supported by studies that show improved clinical and immunological outcomes as well as 
improved quality of life outcomes in children started earlier on ART (Bunupuradah et al., 2013; 
Cotton et al., 2013). There was no significant difference in perceived access to resources and social 
support between the PHIV+ subgroups. There was trend-level evidence (p< 0.1) for greater 
perceived resources in the encephalopathy group which may be because these children were 
accessing medical care at tertiary level hospitals. 
This study is not without limitations. The CBCL relies on subjective reporting of problem 
behaviours and caregivers may have under or over reported behaviours. The HIV-negative status of 
the control group children was not confirmed using HIV testing. Caregiver HIV status and rates of 
parental loss were not determined. These are two important variables that should be explored in 
future studies considering the correlation between caregiver depression and child emotional and 
behavioural problems. Other important child HIV-related variables such as nadir CD4 count and age 
of ART initiation were not measured. The sample size was relatively small which may have limited 
the power of some of the statistical findings. As this is a cross sectional study it is difficult to 
determine the direction of the associations. 
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Conclusion 
This study shows that HIV-infection in children predicts greater emotional and behavioural 
problems when compared to matched HIV-negative controls. In both groups caregiver depression 
was significantly associated with emotional and behavioural problems, although this association was 
stronger in the control group. This highlights the need for adequate screening of depression in the 
caregivers of HIV-infected children as well as caregivers of all children presenting with problem 
behaviours. Treating caregiver depression may help reduce emotional and behavioural problems in 
children in our communities.  
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Tables 
Table 1: Neuropsychological Domains Selected for the Cognitive Performance Score and the 
Tests from the Neuropsychological Test Battery Used for the Z-score Calculation 
Cognitive Domain Test 
Processing speed WISC Processing Speed Index (Wechsler, 2004) 
Attention WISC, TEA-Ch (Manly et al., 2001) 
Visual spatial ability WASI block design (Wechsler, 1999), Rey 
Complex Figure (J. E. Meyers & Meyers, 1995) 
Visual memory Rey Complex Figure recall and delay 
Executive functioning Nepsy inhibition (Korkman, Kirk, & Kemp, 
2007), Nepsy switching, Nepsy naming, 
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Table 2: Demographic, Psychological, Contextual and Biological Variables of Children 
Perinatally Infected with HIV (PHIV+) and HIV-negative Controls  


















-0.41 (0.52) 0.01 (0.55) 
 















2.55 (1.62) 2.63 (1.59) z= 0.51 0.62 





33.01 (14.03) 33.93 (16.52) z= -0.10 0.92 
CESD 
 




24.2    
CD4 count5 806	  (573-1243)  
 
   
FRS= Family Resource Scale, FSS= Family Support Scale, CESD= Center for Epidemiologic 
Studies- Depression Scale, VL= viral load  
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  Summary statistics for continuous variables reported as means, with standard deviation in 
parentheses  
2	   z = z-score from implementation of Mann-Whitney test in R coin package; t=t-score from 
independent t-test, χ = statistical output of chi-squared test    
3	  Other primary caregivers identified were grandmothers, aunts, stepmothers, adoptive mothers 
4	  Total sample = 66 
5	  Total sample = 73; reported as median with interquartile range in parentheses 
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Table 3: Demographic, Psychological, Contextual and Biological Variables of Children 
Perinatally Infected with HIV (PHIV+) Compared by Subgroup: ART Naïve Children, 
Children on ART and Children on ART with Encephalopathy 






Statistical Test2 P-value 







71% 48% 50% χ =2.46 






-0.3 (0.54) -0.4 (0.49) 
 
-0.5 (0.57) F= 0.62  











(people per room) 
 
2.73 (1.98) 2.64 (1.44) 2.16 (1.79) χ = 3.93  
df = 2 
p= 0.14 
FRS 73.15 (23.73) 71.04 (15.85) 83.67 (23.49) F=2.81  




36.08 (20.46) 33.3 (12.19) 30.06 (13.2) F= 0.72  




17.43 (15.27) 15.09 (9.67) 16.39 (11.53) F= 0.26  












χ = 8.863  
df = 2 
p= 0.01* 






χ = 8.048 
df = 2 
p= 0.02* 
FRS= Family Resource Scale, FSS= Family Support Scale, CESD= Center for Epidemiologic 




	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1Summary statistics for continuous variables reported as means, with standard deviation in 
parentheses	  
2	  	  Statistical tests reported as ANOVAS for continuous variables, Chi Squared tests for categorical 
variables; F= F statistic, χ = statistical output of chi-squared test   	  
3	  Viral load reported as % detectable and median with interquartile range in parentheses	  
4	  CD4 count reported as median with interquartile range in parentheses	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Table 4: Correlation Matrix Indicating the Relationship Between Contextual Variables  
 
 
Variable 1 CESD FRS FSS 
FRS2 
 
-0.25  (0.01) *          
FSS2 
 




-0.12 (0.23)         -0.06 (0.55)          -0.13 (0.20)              
CESD= Center for Epidemiological Studies-Depression Scale, FRS= Family Resources Scale, FSS= 
Family Support Scale 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  Reported as Pearsons correlation coefficients with probability value in parentheses	  
2	  One data point is missing for FRS and FSS 
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Table 5: Prevalence of Internalizing, Externalizing and Total Problem Scores at the Clinical 
(>65) and Borderline (>60) Cut-off Ranges on the Child Behaviour Checklist (CBCL) of 
Children Perinatally Infected with HIV (PHIV+) and HIV-negative Controls 
CBCL Scales PHIV+ Children 
 
HIV-negative Children 
 Clinical range  
 








8% (n=6) 22% (n=17) 20% (n=6) 23% (n=7) 
Total Problems 14% (n=11) 19% (n=21) 17 % (n=5) 30% (n=9) 
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Table 6: Child Behaviour Checklist (CBCL) Results in Children Perinatally Infected with HIV 
(PHIV+) and HIV-negative Controls  
 
*= p< 0.1 
  
CBCL Scales PHIV+ Children  HIV-negative Controls  Statistical  Test 
 n Mean SD Median Range n Mean SD Median Range z score p value 
Internalizing Problems 
Anxious/Depressed 78 56.22 7.05 54 50-88 30 57.83 7.9 56 50-88 1.48 0.14 
Withdrawn/ Depressed 78 56.9 7.46 55 50-88 30 55.77 6.03 54 50-66 -0.60 0.55 
Somatic Complaints 78 59.88 8.59 61 50-86 30 57.57 6.91 57 50-76 -1.24 0.22 
Other problems 
Social Problems 78 56.59 6.17 54 50-75 30 55.7 5.79 54 50-75 -0.77 0.44 
Thought Problems 78 55.88 7.62 54 50-82 30 55.23 7.27 51 50-74 -0.44 0.66 
Attention Problems 78 58.24 8.45 55 50-100 30 56.57 9.17 53 50-88 -1.59 0.11 
Externalizing Problems 
Rule-Breaking 
Behaviour 78 55.65 5.74 54.5 50-76 30 55.7 7.39 52 50-76 -0.73 0.46 
Aggressive Behaviour 78 57.96 7.84 57 50-92 30 58.3 10.78 53.5 50-93 -0.90 0.37 
DSM Orientated Scales 
Affective Problems 78 59.82 8.15 60 50-86 30 59.4 7.91 58.5 50-76 -0.14 0.89 
Anxiety Problems 78 54.51 6.43 51 50-75 30 55.9 6.89 54 50-78 0.92 0.36 
Somatic Problems 78 61.1 8.61 61 50-90 30 57.73 7.83 58 50-77 -1.87 0.06* 
Attention 
Deficit/Hyperactivity 
Problems 78 56.82 6.84 55 50-80 30 55.63 6.63 52 50-72 -1.13 0.26 
Oppositional Defiant 
Problems 78 55.1 6.45 52 50-80 30 55.3 7.23 51.5 50-73 -0.85 0.39 
Conduct Problems 78 57.5 7.25 56 50-81 30 57.3 8.42 54 50-78 -0.73 0.46 
 
Internalizing 
Problems  78 57.21 8.52 56.5 34-83 30 56.7 9.31 56 33-83 -0.12 0.91 
 
Externalizing 
Problems  78 56.19 7.54 56 40-78 
 
30 
54.97 11.06 52 34-78 -1.18 0.24 
Total Problems 78 57.51 7.78 57 40-79 
 
30 55.5 10.77 54 25-77 -1.22 0.22 
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Table 7: Estimates for the Final Model of Total Problems 
 Coeff Std Error T P Value 
Model intercept 44.91 2.92 15.37 < 0.001 
HIV status 8.40 3.07 2.74 0.01 
Child gender -2.62 1.49 -1.76 0.08 
Child age 2.88 1.49 1.93 0.06 
Caregiver depression 0.60 0.13 4.53 < 0.001 
HIV status – Depression interaction -0.34 0.15 -2.20 0.03 
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Appendix A Ethics approval letter 
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Appendix B Department of Health approval letter  
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 Directorate: Research 
 
Lower Parliament Street, Cape Town, 8001 Private Bag X9114, Cape Town, 8000 
tel: +27 21 467 9272    fax: 0865902282    Employment and salary enquiries: 0861 92 33 22  










tel: +27 021 467 9272  
Fax:  0865902282 




ENQUIRIES:   Dr A T Wyngaard 
 
Dr Jackie Hoare 





Dear Dr Jackie Hoare 
 
RESEARCH PROPOSAL: THE NEUROPSYCHOLOGICAL AND BEHAVIOURAL PROFILES OF HIV-
INFECTED HAART-NAÏVE CHILDREN 
Your application to conduct the above-mentioned research in schools in the Western Cape has been approved 
subject to the following conditions: 
1. Principals, educators and learners are under no obligation to assist you in your investigation. 
2. Principals, educators, learners and schools should not be identifiable in any way from the results of the 
investigation. 
3. You make all the arrangements concerning your investigation. 
4. Approval for projects should be conveyed to the District Director of the schools where the project will be 
conducted. 
5. Educators’  programmes  are  not  to  be  interrupted. 
6. The Study is to be conducted from 14 January 2013 till 30 September 2013 
7. No research can be conducted during the fourth term as schools are preparing and finalizing syllabi for 
examinations (October to December). 
8. Should you wish to extend the period of your survey, please contact Dr A.T Wyngaard at the contact 
numbers above quoting the reference number?  
9. A photocopy of this letter is submitted to the principal where the intended research is to be conducted. 
10. Your research will be limited to the list of schools as forwarded to the Western Cape Education 
Department. 
11. A brief summary of the content, findings and recommendations is provided to the Director:  Research 
Services. 
12. The Department receives a copy of the completed report/dissertation/thesis addressed to: 
          The Director: Research Services 
Western Cape Education Department 
Private Bag X9114 
CAPE TOWN 
8000 
We wish you success in your research. 
 
Kind regards. 
Signed: Dr Audrey T Wyngaard 
for: HEAD: EDUCATION 
DATE: 13 September 2012 
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Appendix D Consent form HIV-infected child participants 
PATIENT INFORMATION AND CONSENT FORM 
FOR THE STUDY 
Diffusion Tensor Imaging of HIV-positive Children and Their Psychocognitive and 
Behavioural Profiles. 
HIV Positive patients 
Principal Investigator: Dr J Hoare 
Dear Participant 
You and your child are requested to participate in a medical research study that is being done 
at Red Cross Children’s Hospital in the School of Child and Adolescent Health, University of 
Cape Town. The following describes the study and you and your child’s role. Please take some 
time to read the information presented here carefully, and feel free to ask any questions.  
Background  
We are doing a study on how HIV affects children’s learning, development and behaviour. We want 
to compare tests of development (learning, memory, language and attention), psychosocial scales 
(trauma, life events, depression, anxiety and adaptability) and brain scans from children with HIV to 
children who do not have HIV. 
If you are willing to allow your child to participate in this study, your child must be HIV positive and 
currently not physically ill.  
HIV infection may cause slow development in a child. This can be either because of the virus itself 
or infections that the child may get. Even if a child seems well and is going to school, the HIV 
infection may affect some functions - like interfering with learning, with good memory, with doing 
mathematics, and with attention and behaviour.  
We also want to learn about how caring for a child affects you as a parent. Parents, who have to care 
of a HIV-positive child, may experience more stress and difficulties than parents whose children do 
not have HIV. We want to compare test of parental stress of parents of children who are HIV-
positive, to parents of children who are HIV-negative. 
Children are often exposed to different kinds of trauma under various circumstances. We would like 
to find out more about the kinds of trauma certain children may experience. 
Purpose of the Study 
The aim of this study is to measure tests of development (learning, memory, language, attention) and 
tests of behaviour and brain scans in healthy HIV-positive children and in healthy HIV negative 
children. The HIV-positive children’s performance will be compared to the performance of healthy 
HIV-negative children. This will improve our understanding and management of children with HIV.  
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Procedures in the Study 
Your involvement in the study will require you to visit the study doctor/team on three occasions. 
Two of the sessions will take place at Red Cross Children’s Hospital (RXH), and during these 
sessions neuropsychological, developmental and behavioural tasks will be completed by your child. 
This includes the brain scan, but this will be done at Tygerberg Hospital. 
Confirmation of HIV diagnosis 
If you are invited to participate in this study, it means that your child has already been diagnoses as 
being HIV positive, and has been referred to this study. Your child is unique in that he/she will have 
acquired the infection via mother to child transmission, and not via a blood transfusion or 
unhygienic needles. 
Your child is currently attending a clinic for regular checkups. With your permission, we will 
contact the clinic which you and your child are attending to gain access to information in your clinic 
folders. During the course of your participation you will be asked certain medical questions 
regarding your child most recent CD4 count, viral load, and current treatment regime. 
Neuropsychological and psychological testing 
The study research assistant will ask your child to complete a number of pencil and paper tests 
which involve some writing and drawing as we tests their memory, concentration and planning 
abilities. Many of these are like a normal IQ test that your child may have completed at school. All 
of these tests are important and will help us to determine if HIV has any effects on these aspects for 
your child’s brain. This session will take approximately 2½ - 3 hours long. At another session you 
child will be asked questions about what kinds of things they have experienced in their everyday 
lives, as well as questions about their emotional state. 
While your child completes these tasks, we will ask you as the parent / guardian to complete 
psychological measures pertaining to your child’s overall development, as well as your experiences 
as a parent. These tests are important and will help us to determine the amount of stress and anxiety 
you may experience as a parent, and how this relates to your child’s development. 
Brain scanning procedure  
All brain scans will be done at a specialized facility at Tygerberg Hospital. A special brain scan (an 
MRI scan) will be done on your child – this examination is not harmful and it is not painful. Your 
child will be asked to lie still on a special bed while the scanner takes the pictures of your child’s 
head - this will be for a maximum of 30 minutes. Some children may find the machine a bit scary. If 
your child is very anxious or scared or unable to lie still for that long, we will not continue with the 
examination.  
Neurological examination 
You child will be required to undergo a neurological examination which will be performed by a 
study doctor. The purpose of this examination is to check that your child’s sensory and motor 
responses, and also their reflexes, are functioning properly and that there is no damage to their 
nervous system. To test this, the doctor will ask your child to do a series of playful activities, for 
example touching their nose or their ankles. These tasks are not harmful to your child. If your child 
is anxious, you may accompany him/her in the examination room. 
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Procedure for drawing of bloods 
This part of the study involves the long-term storage of DNA (genetic) taken from a sample of your 
child’s blood for future analysis. Genetic material, also called DNA, can be obtained from small 
samples of blood. Previous studies have shown that HIV infection can have damaging effects on the 
brain. We are however unsure as to how serious these effects may be in young children. In this part 
of the study, we hope one day to be able to use genetic material, such as we will be collecting, to 
assist us in identifying genes that will tell is what people may be particularly vulnerable to 
experience harmful effects, and what genetic patterns are likely to make people more susceptible to 
becoming infected with the HIV virus. Before the brain scan is done, a registered nurse will draw a 
small amount of blood from your child. This procedure will not be harmful to your child. Your child 
may feel a light prick when the needle is inserted into his/her arm, but will not experience any pain. 
The needle is connected to a thin plastic pipe and the blood then flows into a small blood sample 
tube. The test will require about 1 teaspoon of blood, and is performed only once.  
Your blood will only be used for genetic research that is directly related to this study looking and 
diffusion tensor in HIV-infected children. Also if the researchers wish to use your stored blood for 
additional research in this field they will be required to apply for permission to do so from the 
Human Research Ethics Committee at UCT. If you do not wish your blood specimen to be stored 
after this research study is completed you will have an opportunity to request that it be discarded 
when you sign this consent form. 
Follow ups 
You and your child may be asked to attend a follow up session. If you are asked to come for a follow 
up, it will be one year from the date of your first enrollment to this study. The study procedures for 
the follow up, will be the same as for this time. 
Your Part in the Study 
While your child is being tested by members of the study team, you will also be asked to completed 
questions by another member of the study. You will complete a general demographics form, and 
other psychological tests pertaining to your child’s mental health and yours. These tests are not 
harmful, but may ask some sensitive questions about your life. Our researchers will do all they can 
to emotionally support you while you complete these forms. It is important for us that you answer 
these questions truthfully, so that we can better understand you as a parent, and your needs.  
For the first session, a trained research assistant will interview your child at RXH. During this 
session your child will complete the neuropsychological tasks previously described. During the 
second session, a registered social worker will interview your child about their behavioural and 
emotional well-being. Your child will then be given another appointment to go Tygerberg hospital, 
on a day that is convenient for you, where the brain scan will be done. We will try to arrange these 
sessions so as to not interfere with your child’s normal school routine. These sessions may be 
booked after school hours where possible. Transport money and food vouchers will be provided for 
you and your child for each these visits.  
 
Risks to You and Your Child 
There are only low or minimal risks associated with your participation in this study. If you feel tired 
at any point during any of the visits, you should please ask your study doctor/psychologist for a rest. 
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If for some reason you are unable to complete a visit on a particular day we may reschedule to 
complete the assessments at another time.  
There are no direct risks in having blood taken for genetic testing. 
Furthermore, there are no known risks for your child for either the psychological tests or the brain 
scan. The brain scan does not involve any radiation.  
Benefits to You and Your Child 
Although there is no direct benefit for you or your child, the results of this research may help to 
inform us to what the common school and behaviour problems are that healthy HIV-positive 
children can have. This will help us to decide if we need to consider extra treatments and/or 
interventions for these children.  
Confidentiality 
You and your child’s test results will be kept confidential (private) and will only be used by the 
members of this study for the purpose of research. If any information from this study gets published, 
we will make sure that your personal details will remain confidential at all times.  
This study has been approved by the Committee for Human Research of the University of Cape 
Town (UCT). It will be conducted according to Medical Research Council guidelines on good 
clinical practice (2003) as well as the Declaration of Helsinki Guidelines (Edinburgh, 2000), which 
provide detailed guidelines that relate to the ethical conduct of studies involving human subjects. 
Voluntary Participation 
You and your child’s participation are entirely voluntary. You or your child is not under any 
obligation to participate. If you choose not to allow your child to participate, it will not affect you or 
your child negatively or prevent your right to future health care services. You have the right to 
withdraw your child from the study at any time.  
You have the right to ask questions at any time about any aspect of the study. If you have any 
queries, you can contact Jackie Hoare on 021 404 2134/2164 
You are entitled to a signed copy of this document. 
If you agree to take part, please complete the following section: 
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ASSENT OF MINOR 
 
I (Name of Child/Minor) ______________________________________ have been invited to take 
part in the above research project entitled: Diffusion Tensor Imaging of HIV-positive Children 
and Their Psychocognitive and Behavioural Profiles. 
 
The study doctor/nurse and my parents have explained the details of the study to me and I 
understand what they have said to me. 
• They have also explained that this study will involve 3 assessments which include 
interviews, filling questionnaires, a physical examination, blood sampling, and a brain scan. 
• I also know that I am free to withdraw from the study at any time if I am unhappy. 
• By writing my name below, I voluntarily agree to take part in this research project.  I 




Name of child  (To be written by the child if possible) 
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DECLARATION BY PARENT/LEGAL GUARDIAN 
 
By signing below, I (name of parent/legal guardian) ____________________________________ 
agree to allow my child (name of child) _______________________________ who is ___ years old, 
to take part in a research study entitled: Diffusion Tensor Imaging of HIV-positive Children and 
Their Psychocognitive and Behavioural Profiles. 
I declare that: 
• I have read or had read to me this information and consent form and that it is written in a 
language with which I am fluent and comfortable. 
• If my child is older then 7 years, he/she must agree to take part in the study and his/her 
ASSENT must be recorded on this form. 
• I have had a chance to ask questions and all my questions have been adequately answered. 
• I understand that taking part in this study is voluntary and I have not been pressurised to let 
my child take part. 
• I may choose to withdraw my child from the study at any time and my child will not be 
penalised or prejudiced in any way. 
• My child may be asked to leave the study before it has finished if the study doctor or 
researcher feels it is in my child’s best interests, or if my child does not follow the study 
plan as agreed to. 
• I understand that genetic material will be collected from blood samples 
 
 I agree that my child’s blood sample can be stored for research purposes, subject to the 
approval of the Human Research Ethics Committee (HREC) of UCT, provided that all 
information is kept confidential. I can choose to request at any time that my stored 
sample be destroyed. I have the right to receive confirmation that my request has been 
carried out. 
OR 
 Please destroy my blood sample as soon as the current research project has been 
completed.  (Tick the option you choose) 
 
Signed at (place) ________________________ on (date) _______________20____ 
_______________________________ 
Signature of parent/legal guardian  
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DECLARATION BY INVESTIGATOR 
 
I (name) _________________________________________ declare that: 
• I explained the information in this document to  
 (name of child and parent)_________________________________________ 
 I encouraged him/her to ask questions and took adequate time to answer them. 
• I am satisfied that he/she adequately understand all aspects of the research, as discussed 
above. 
• I did/did not use an interpreter (if an interpreter is used, then the interpreter must sign the 
declaration below). 
Signed at (place) ________________________ on (date) ______________20_____ 
 
________________________ 
Signature of investigator  
 
DECLARATION BY INTERPRETER 
 
I (name) ________________________________________. declare that: 
• I assisted the investigator (name) _________________________________  
 to explain the information in this document to  
 (name of parent/legal guardian) __________________________________  
  using the language medium of Afrikaans / Xhosa. 
• We encouraged him/her to ask questions and took adequate time to answer them. 
• I conveyed a factually correct version of what was related to me. 
• I am satisfied that the parent/legal guardian fully understands the content of this informed 
consent document and has had all his/her questions satisfactorily answered. 
 




Signature of interpreter   
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Appendix E Consent form HIV-negative child participants 
PATIENT INFORMATION AND CONSENT FORM 
FOR THE STUDY 
 
Diffusion Tensor Imaging of HIV Affected Children and Their Psychocognitive and 
Behavioural Profiles. 
 
HIV Negative controls 
Principle Investigator: Dr J Hoare 
Dear Participant 
You and your child are requested to participate in a medical research study that is being done 
at Red Cross Children’s Hospital in the School of Child and Adolescent Health, University of 
Cape Town. The following describes the study and you and your child’s role. Please take some 
time to read the information presented here carefully, and feel free to ask any questions.  
Background  
We are doing a study on how HIV affects children’s learning, development and behaviour. We want 
to compare tests of development (learning, memory, language and attention), psychosocial scales 
(trauma, life events, depression, anxiety and adaptability) and brain scans from children with HIV to 
children who do not have HIV. 
You may participate in this study if your child is healthy and not HIV positive.  
Infection may cause slow development in a child. This can be either because of the virus itself or 
infections that the child may get. Even if a child seems well and is going to school, the infection may 
affect some functions - like interfering with learning, with good memory, and with attention and 
behaviour.  
We also want to learn about how caring for a child affects you as a parent. Parents, who have to care 
of a positive child, may experience more stress and difficulties than parents who have children who 
are negative. We want to compare test of parental stress of parents of children who are negative, to 
parents of children who are positive. 
Children are often exposed to different kinds of trauma under various circumstances. We would like 
to find out more about the kinds of trauma certain children may experience. 
Purpose of the Study 
The aim of this study is to measure tests of development (learning, memory, language, attention) and 
tests of behaviour and brain scans in healthy positive children and in healthy negative children. The 
positive children’s performance will be compared to the performance of healthy negative children. 
This will improve our understanding and management of children with HIV.  
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Procedures in the Study 
Your involvement in the study will require you to visit the study doctor/team on three occasions. 
Two of the sessions will take place at Red Cross Children’s Hospital (RXH), and during these 
sessions neuropsychological, developmental and behavioural tasks will be completed by your child. 
The brain scan will be done at the third session, and this will take place at Tygerberg Hospital’s 
(TBH) Cape Universities Brain Imaging Center (CUBIC). 
Neuropsychological and psychological testing 
The study research assistant will ask your child to complete a number of pencil and paper tests 
which involve some writing and drawing as we tests their memory, concentration and planning 
abilities. Many of these are like a normal IQ test that your child may have completed at school. All 
of these tests are important and will help us to determine if HIV has any effects on these aspects for 
your child’s brain. This session will take approximately 2½ - 3 hours long. At another session you 
child will be asked questions about what kinds of things they have experienced in their everyday 
lives, as well as questions about their emotional state. 
While your child completes these tasks, we will ask you as the parent / guardian to complete 
psychological measures pertaining to your child’s overall development, as well as your experiences 
as a parent. These tests are important and will help us to determine the amount of stress and anxiety 
you may experience as a parent, and how this relates to your child’s development. 
Brain scanning procedure 
All brain scans will be done at a specialized facility at Tygerberg Hospital. A special brain scan (an 
MRI scan) will be done on your child – this examination is not harmful and it is not painful. Your 
child will be asked to lie still on a special bed while the scanner takes the pictures of your child’s 
head - this will be for a maximum of 45 minutes. During that time your child may rest and close 
his/her eyes. Having an MRI scan done is a safe procedure if you and your child have been screened 
correctly for the presence of any magnetic material on or inside you such as pace-makers, surgical 
clips and metal objects. A formal screen for this will be done by one of the study research assistants 
prior to the scanning session. When the magnet inside the machine is switched on, it will make some 
loud banging noises. At this time you will feel nothing and the noise is not harmful to you or your 
child in any way. Your child will be given soft ear plugs to wear during the procedure to minimize 
possible discomfort associated with this experience.  
Some children may find the machine a bit frightening. If your child is very anxious or scared, you 
will be allowed to accompany your child inside the scanning room. We will make sure that it is safe 
for both you and your child to go inside the MRI scanning room and to undergo scanning. Your 
child may feel slightly dizzy immediately after the scan. This is completely normal. The 
radiographers at the scanning center are qualified and trained to be alert to the effects of the 
scanning procedure on participants. Your child’s need will be attended to immediately, should the 
need arise. We will make every effort to ensure that your child is comfortable doing the scan. 
Materials will be provided to prepare your child before the scan, for example a flow diagram for the 
scanning procedure, as well as a video. If your child is still afraid or unable to lie still for that long, 
we will not continue with the examination.  
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Follow ups 
You and your child may be asked to attend a follow up session. If you are asked to come for a follow 
up, it will be one year from the date of your first enrollment to this study. The study procedures for 
the follow up, will be the same as for this time. 
Your Part in the Study 
While your child is being tested by members of the study team, you will also be asked to completed 
questions by another member of the study. You will complete a general demographics form, and 
other psychological tests pertaining to your child’s mental health and yours. These tests are not 
harmful, but may ask some sensitive questions about your life. Our researchers will do all they can 
to emotionally support you while you complete these forms. It is important for us that you answer 
these questions truthfully, so that we can better understand you as a parent, and the difficulties you 
experience while caring for your child. 
For the first session, a trained research assistant will interview your child at RXH. During this 
session your child will complete the neuropsychological tasks previously described. During the 
second session, a registered social worker will interview your child about their behavioural and 
emotional well-being. Your child will then be given another appointment to go Tygerberg hospital, 
on a day that is convenient for you, where the brain scan will be done. We will try to arrange these 
sessions so as to not interfere with your child’s normal school routine. These sessions may be 
booked after school hours where possible. Transport money and food vouchers will be provided for 
you and your child for each these visits.  
 
Risks to You and Your Child 
If you or your child feels tired at any point during any of the visits, you should ask your study 
doctor/psychologist for a rest. If for some reason you are unable to complete a visit on a particular 
day we may reschedule to complete the assessment at another time. 
Furthermore, there are no known risks for your child for either the psychological tests or the brain 
scan. The brain scan does not involve any radiation.  
Benefits to You and Your Child 
Although there is no direct benefit for you or your child, the results of this research may help to 
inform us to what the common school and behaviour problems are that healthy HIV-positive 
children can have. This will help us to decide if we need to consider extra treatments and/or 
interventions for these children.  
We acknowledge that we cannot provide intervention or treatment, as part of this study. If it is 
detected that your child has developmental delay, we will provide you will a detailed report, and 
with your permission we will forward it to the relevant educational department to be dealt with 
accordingly. A detailed report will be important in determining what type of intervention your child 
may need. Further treatment for your child will be at your own expense. 
Confidentiality 
You and your child’s test results will be kept confidential (private) and will only be used by the 
members of this study for the purpose of research. If any information from this study gets published, 
we will make sure that your personal details will remain confidential at all times.  
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This study has been approved by the Human Research Ethics Committee (021 406 6492) of the 
University of Cape Town (UCT). It will be conducted according to Medical Research Council 
guidelines on good clinical practice (2003) as well as the Declaration of Helsinki Guidelines 
(Edinburgh, 2008), which provide detailed guidelines that relate to the ethical conduct of studies 
involving human subjects. 
Voluntary Participation 
You and your child’s participation are entirely voluntary. You or your child is not under any 
obligation to participate. If you choose not to allow your child to participate, it will not affect you or 
your child negatively or prevent your right to future health care services.  
You have the right to withdraw your child from the study at any time.  
 
You have the right to ask questions at any time about any aspect of the study. If you have any 
queries, you can contact Jackie Hoare on 021 404 2134/2164.  
 
You are entitled to a signed copy of this document. 
 
If you agree to take part, please complete the following section: 
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ASSENT OF MINOR 
 
I (Name of Child/Minor) ______________________________________ have been invited to take 
part in the above research project entitled: Diffusion Tensor Imaging of HIV-positive Children 
and Their Psychocognitive and Behavioural Profiles. 
 
The study doctor/nurse and my parents have explained the details of the study to me and I 
understand what they have said to me. 
• They have also explained that this study will involve 3 assessments which include 
interviews, filling questionnaires, a physical examination, and a brain scan. 
• I also know that I am free to withdraw from the study at any time if I am unhappy. 
• By writing my name below, I voluntarily agree to take part in this research project. I confirm 




Name of child  (To be written by the child if possible) 
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DECLARATION BY PARENT/LEGAL GUARDIAN 
 
By signing below, I (name of parent/legal guardian) ____________________________________ 
agree to allow my child (name of child) _______________________________ who is ___ years old, 
to take part in a research study entitled: Diffusion Tensor Imaging of HIV-positive Children and 
Their Psychocognitive and Behavioural Profiles. 
 
I declare that: 
• I have read or had read to me this information and consent form and that it is written in a 
language with which I am fluent and comfortable. 
• If my child is older than 7 years, he/she must agree to take part in the study and his/her 
ASSENT must be recorded on this form. 
• I have had a chance to ask questions and all my questions have been adequately answered. 
• I understand that taking part in this study is voluntary and I have not been pressurised to let 
my child take part. 
• I may choose to withdraw my child from the study at any time and my child will not be 
penalised or prejudiced in any way. 
• My child may be asked to leave the study before it has finished if the study doctor or 
researcher feels it is in my child’s best interests, or if my child does not follow the study 
plan as agreed to. 
 
 




Signature of parent/legal guardian  
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DECLARATION BY INVESTIGATOR 
 
I (name) _________________________________________ declare that: 
• I explained the information in this document to  
 (name of child and parent)_________________________________________ 
 I encouraged him/her to ask questions and took adequate time to answer them. 
• I am satisfied that he/she adequately understand all aspects of the research, as discussed 
above. 
• I did/did not use an interpreter (if an interpreter is used, then the interpreter must sign the 
declaration below). 
 
Signed at (place) ________________________ on (date) ______________20_____ 
 
________________________ 
Signature of investigator 
 
DECLARATION BY INTERPRETER 
 
I (name) ________________________________________. declare that: 
 
• I assisted the investigator (name) _________________________________  
 to explain the information in this document to  
 (name of parent/legal guardian) __________________________________  
  using the language medium of Afrikaans/Xhosa. 
• We encouraged him/her to ask questions and took adequate time to answer them. 
• I conveyed a factually correct version of what was related to me. 
• I am satisfied that the parent/legal guardian fully understands the content of this informed 
consent document and has had all his/her questions satisfactorily answered. 
 
Signed at (place) ________________________on (date) _______________20____ 
_____________________ 
Signature of interpreter  
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• Manuscripts are accepted in English. Any consistent spelling and punctuation styles may be used. Please use 
double quotation marks, except where “a quotation is ‘within’ a quotation”. Long quotations of 40 words or 
more should be indented without quotation marks. 
• You should prepare and upload two versions of your manuscript. One should be a complete text; the other 
should have all information identifying the author removed from files to allow them to be sent anonymously to 
referees. Upload the anonymised version as a "Main Document" and the complete text as a "File not for 
Review". 
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should be double spaced, with ample margins of at least one inch. Footnotes to the text should be avoided 
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Please supply all details required by any funding and grant-awarding bodies as an acknowledgement in a 
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This work was supported by the <Funding Agency> under Grant <number xxxx>.  
For multiple agency grants  
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• All authors of a manuscript should include their full names, affiliations, postal addresses, telephone numbers 
and email addresses on the cover page of the manuscript. One author should be identified as the 
corresponding author. Please give the affiliation where the research was conducted. If any of the named co-
authors moves affiliation during the peer review process, the new affiliation can be given as a footnote. Please 
note that no changes to affiliation can be made after the manuscript is accepted. Please note that the email 
address of the corresponding author will normally be displayed in the article PDF (depending on the journal 
style) and the online article. 
• All persons who have a reasonable claim to authorship must be named in the manuscript as co-authors; the 
corresponding author must be authorized by all co-authors to act as an agent on their behalf in all matters 
pertaining to publication of the manuscript, and the order of names should be agreed by all authors. 
• Biographical notes on contributors are not required for this journal. 
• Please supply all details required by any funding and grant-awarding bodies as an Acknowledgement on the 
title page of the manuscript, in a separate paragraph, as follows: 
• For single agency grants: "This work was supported by the [Funding Agency] under Grant [number 
xxxx]." 
• For multiple agency grants: "This work was supported by the [Funding Agency 1] under Grant [number 
xxxx]; [Funding Agency 2] under Grant [number xxxx]; and [Funding Agency 3] under Grant [number 
xxxx]." 
• Authors must also incorporate a Disclosure Statement which will acknowledge any financial interest or benefit 
they have arising from the direct applications of their research. 
• For all manuscripts non-discriminatory language is mandatory. Sexist or racist terms must not be used. 
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• When using a word which is or is asserted to be a proprietary term or trade mark, authors must use the 
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Appendix G Socio-demographic Questionnaire 
DEMOGRAPHICS QUESTIONNAIRE 
Please circle where appropriate. Please describe extra information.  
 
A. PARENT / CAREGIVER DEMOGRAPHICS 
Gender:   MALE  FEMALE 
Age: ___________________  DOB: _____________________________ 
Marital status:  MARRIED SINGLE DIVORCED WIDOWED 
Race: WHITE  COLOURED  BLACK AFRICAN  OTHER 
Are you dependent on a government grant?    YES 
 NO 
If yes, please specify: _______________________________ 
 
B. OBSTETRICS HISTORY 
Any birth complications:      YES 
 NO 
If yes, please specify:  
___________________________________________________ 
Emergency C-section:       YES 
 NO 
If yes, please explain:  
__________________________________________________ 
Routine check-ups followed:      YES 
 NO 
If no, why not:  
_______________________________________________________ 
Alcohol use during pregnancy:     YES 
 NO 
If yes, please explain (frequency and quantity):  
_____________________________ 
Drug use during pregnancy:      YES 
 NO 
If yes, please explain (quantity, frequency and type):  
_________________________ 
 
C. CHILD / PATIENT DEMOGRAPHICS 
Sex:   MALE  FEMALE 
Age: _________________________________ 
DOB: ________________________________ 
Race:  WHITE COLOURED  BLACK AFRICAN  OTHER 
 If other, please specify: ______________________ 
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Religion: ______________________________ 
Home Language:   ENGLISH AFRIKAANS  isiXhosa OTHER 
Other languages in which your child is fluent: _________________________ 
 
CHILD / PATIENT MEDICAL HISTORY 
Significant / traumatic head injuries:      YES 
 NO 
If yes, please specify the following: 
When/how long ago: 
___________________________________________________ 
Was child unconscious (could not wake child up): 
___________________________________________________ 
Was child hospitalised and for how long: 
___________________________________________________ 
Did the child require stitches: 
___________________________________________________ 
Brain scans done and when: 
____________________________________________________ 
 
Previous Alcohol use:       YES 
 NO 
Current Alcohol use:       YES 
 NO 
If yes, please specify quantity and frequency: 
________________________________ 
 
Previous Drug use:       YES 
 NO 
Current Drug use:       YES 
 NO 
If yes, please specify quantity, frequency and type: 
______________________________________________________________ 
 
Has your child ever been diagnosed with any psychiatric illness: eg: depression, 
psychosis, anxiety, etc:       YES 
 NO 
If yes, please specify: 
__________________________________________________ 
Is your child currently receiving treatment for a psychiatric illness: YES 
 NO 
If yes, please explain: 
__________________________________________________ 
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Please explain your child’s current HAART treatment regime:  
First line / Second line / Third line 
Describe: __________________________________________________ 
 
Has your child had any HIV related illnesses:    YES 
 NO 
If yes, please specify: eg: TB, pneumonia, meningitis, etc. 
______________________________________________________________ 
 
Is your child currently receiving treatment for an HIV related illness:  YES 
 NO 
If yes, please explain: 
__________________________________________________ 





Does your child have any other medical conditions:    YES 
 NO 
If yes, please specify: eg: diabetes, asthma, epilepsy, etc: 
______________________________________________________________ 
 
D. EDUCATION LEVEL OF CHILD 




Current School setting:   RURAL   URBAN 
 Name of school: ____________________________________ 
 
Has he/she repeated any grades at school?    YES 
 NO 
 If yes, which grade(s): _____________________ 
 
Has your child ever (current or previous) had remedial help at school:  
YES 
 NO 
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If your child is not currently attending school, please specify their daily activities.  
Are they at home? At a care facility? Etc. 
____________________________________________________________________
____________________________________________________________________	  
E. GENERAL INFORMATION 
Which best describes the area you live in? 
SURBURBAN  URBAN  RURAL TOWNSHIP  
 
What is the name of the area you live in? 
______________________________________________________	  
 
Living structure: Brick house / Shack / Wooden wendy house 
If other, describe: _________________________________________ 
 
Size of the house (number of rooms in the house): 
            _______________________________________________________	  
Number of people who live in the house:  
_______________________________________________________ 
Who lives in your house (e.g., father, mother, grandmother, etc): 
_______________________________________________________ 
 
Do you have the following amenities in your home: 
i. Electricity / Gas      YES 
 NO 
ii. Adequate clothing for child     YES 
 NO 
iii. Enough food to eat for at least 2 meals per day  YES 
 NO 
iv. Child’s own study/homework area or space   YES 
 NO 
  
	   79	  
Appendix H Child Behaviour Checklist Results across the HIV subgroups 
 
Within the HIV-infected group, children were further divided into three subgroups: PHIV+ children 
who had never been on antiretroviral therapy (ART naïve), PHIV+ children on ART and PHIV+ 
children on ART with a confirmed diagnosis of HIV-related encephalopathy. Appendix H shows the 
CBCL results across the three HIV subgroups. Some variability was observed with respect to the 
distribution of total problem scores between these groups, with children on ART having fewer 
emotional and behavioural problems when compared to ART naïve and children on ART with 
encephalopathy (F=6.188, df=2.75, p<0.01).  
 
  
